You should be aware that in attempting to have an intelligent discussion with Hubby, you're dealing with somebody whose intellectual development never progressed beyond binary concepts.
If you take a closer look at his argument you'll see that he doesn't understand "non-event".
If Friday's PR wasn't bad news, it must have been good news. If it was good news, the Company wouldn't have waited until the Friday evening before a long break to release it - so it must have been bad news.
I just hope he's telling the truth when he claims that the value of his INSM investment alone is just 70K short of half a million dollars. Brain transplants are not cheap.
In the Land of Gunfick Traders Terry would be King. But this guy would be President.
a "friendly" warning? Fud: you have no friends, not here and probably not anywhere.
Hubby is a genuine long-term Insmed investor with real skin in the game, who has been defrauded by
• the strategic review
• transave reverse merger (valuing Insmed at BELOW cash-on-hand)
• reverse split
• reverse split not applied to the authorized shares
• organized insider short selling
• "accidental" clinical holds
• dilution of new stock sold below book value to transave VCs
• "sale" of iplex to premacure/Shire for $11.5M (which you espoused for years is worth billion$)
• an S-3 shelf indicating to shorts that they need not worry about a short squeeze
Everyone knows you not a shareholder with any real investment here.
Hypothetically. Can you explain to me with your business management experience where would Insmed be without the Transave merger?
What would you have done with the remaining cash on hand? What would you have done with a non revenue earning company to make it an ongoing concern that has positive earnings and an increased share price to the shareholders, who knew they were investing in a more than highly risky business with odds of success of less than 10%?